A Comparative Study to Assess Efficacy of Intralesional MMR Vaccine and Intralesional Vitamin D3 in Treatment of Warts (MMR)
A Comparative Study to Assess Efficacy of Intralesional MMR (Measles, Mumps, Rubella) Vaccine and Intralesional Vitamin D3 in Treatment of Warts
Sponsor: B.P. Koirala Institute of Health Sciences
Listed as NCT04428359, this NA trial focuses on Verruca Viral and remains completed. Sponsored by B.P. Koirala Institute of Health Sciences, it has been updated 8 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 3 earlier versions
-
May 2021 — Dec 2022 [monthly]
Completed NA
-
Jan 2021 — May 2021 [monthly]
Completed NA
Status: Not Yet Recruiting → Completed
-
Jul 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Jun 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- B.P. Koirala Institute of Health Sciences
- Nepal Health Research Council
For direct contact, visit the study record on ClinicalTrials.gov .